All News

An experimental treatment for urinary tract infections has passed its first test in animals, alleviating weeks-long infections in mice in as little as 6 hours, according to a recent study.

Female stress urinary incontinence treatment with single-incision mini-slings yields significantly lower cure rates and higher risk of repeat surgery compared with standard midurethral slings.

If you are serious about going green, get your staff involved. Start with conducting an environment audit of what products you use, how they are discarded, and where there may be unnecessary waste.

Staring down a possible 27% reimbursement cut, questions about the viability of health care reform, increasing demand for their services, and a shrinking work force, it's less than surprising that urologists are anxious about the prospects for their profession.

Urologists generally use the recommendation as the basis of a frank discussion with patients.

Even if they didn't do well in the stock market, many focus on their health and enjoy their work.

Kenneth M. Peters, MD, discusses the various forms of neurostimulation, current research efforts, and potential future uses for this modality.

Urologists and other health care providers now need to consider whether to participate in the federal government's new accountable care organization program, finalized in mid-October as a way to help reduce Medicare costs while improving patient care.

This article reviews the current data on KTP laser vaporization and HoLEP, emphasizing outcomes compared with those of TURP and OP, to determine whether a new gold standard exists for the surgical management of BPH/LUTS.

By the end of this article, you should better understand the VA practice model as it relates to the practice of urology.

Findings from a large cohort of men with post-radical prostatectomy incontinence provide some insight on the diagnostic benefit of videourodynamic studies for guiding management decisions.

From a marketable government debt securities standpoint, investors are offered many choices.

High serum levels of certain antioxidants are associated with a lower risk of nephrolithiasis.

Virtually every source of income from patient care to ancillary services is being cut for all specialty physicians, not just urologists.

In men with castration-resistant prostate cancer and symptomatic bone metastases, the investigational radiopharmaceutical radium-223 (Alpharadin) improved overall survival by 30% and time to first skeletal-related event by 39% compared with placebo.

In stress continent women, prophylactic placement of a midurethral sling at the time of vaginal prolapse repair significantly decreases the development of bothersome urinary incontinence, even after allowing for delayed incontinence intervention.

We once again approach the end of the year with the American Medical Association, many legislators, and Health and Human Services Secretary Kathleen Sebelius calling for a permanent fix to the sustainable growth rate formula, with no action by Congress.

Placing a patient in a "prone-flexed" position offers a number of benefits for percutaneous nephrolithotomy.

Statin use in patients with hyperlipidemia appears to protect against urinary stone formation.

The newest urology products and services from Eli Lilly and Co., Watson Pharmaceuticals, Inc., BK Medical, Olympus America, Inc., Henry Schein MicroMD, American Medical Systems, and Segasist Technologies.

For the protection and promotion of urologic patients and practices, we must break down artificial barriers that impede progress.

Astellas Pharma, Inc, has announced the receipt of a letter from the FDA indicating that it accepted for filing the new drug application for mirabegron (YM178) and initiated a substantive review.

The use of multiple medications is associated with increased severity of erectile dysfunction, say researchers from Kaiser Permanente Los Angeles Medical Center.

Dendreon Corp. has announced that the Centers for Medicare & Medicaid Services has updated its coverage policy to now cover the infusion costs associated with the administration of the advanced prostate cancer immunotherapy sipuleucel-T (Provenge).

Treatment with the RANK ligand inhibitor denosumab (XGEVA) is effective at delaying the development of bone metastases in men with nonmetastatic castration-resistant prostate cancer, according to a recent multicenter study.

An international research team has discovered a genetic Achilles' heel in neuroendocrine prostate cancer-a vulnerability that researchers say can be attacked by a targeted drug that is already in clinical trials to treat other types of cancers.

Pacific Urology and Diablo Valley Oncology and Hematology Medical Group, both located in Contra Costa County in California, are merging to form a 13-physician group.